- Home
- AZZ vs SUPN Comparison
AZZ vs SUPN Comparison
Compare AZZ & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZZ
- SUPN
- Stock Information
- Founded
- AZZ 1956
- SUPN 2005
- Country
- AZZ United States
- SUPN United States
- Employees
- AZZ N/A
- SUPN N/A
- Industry
- AZZ Industrial Specialties
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- AZZ Industrials
- SUPN Health Care
- Exchange
- AZZ Nasdaq
- SUPN Nasdaq
- Market Cap
- AZZ 2.3B
- SUPN 1.9B
- IPO Year
- AZZ N/A
- SUPN 2012
- Fundamental
- Price
- AZZ $82.98
- SUPN $35.57
- Analyst Decision
- AZZ Buy
- SUPN Hold
- Analyst Count
- AZZ 6
- SUPN 1
- Target Price
- AZZ $95.80
- SUPN $36.00
- AVG Volume (30 Days)
- AZZ 155.9K
- SUPN 422.4K
- Earning Date
- AZZ 01-07-2025
- SUPN 11-04-2024
- Dividend Yield
- AZZ 0.82%
- SUPN N/A
- EPS Growth
- AZZ 17.78
- SUPN 130.79
- EPS
- AZZ 1.08
- SUPN 1.07
- Revenue
- AZZ $1,570,389,000.00
- SUPN $651,972,000.00
- Revenue This Year
- AZZ $4.77
- SUPN $7.82
- Revenue Next Year
- AZZ $5.34
- SUPN N/A
- P/E Ratio
- AZZ $76.44
- SUPN $33.25
- Revenue Growth
- AZZ 4.75
- SUPN 6.79
- 52 Week Low
- AZZ $48.03
- SUPN $25.53
- 52 Week High
- AZZ $88.67
- SUPN $39.37
- Technical
- Relative Strength Index (RSI)
- AZZ 55.71
- SUPN 53.46
- Support Level
- AZZ $82.81
- SUPN $35.87
- Resistance Level
- AZZ $87.15
- SUPN $39.37
- Average True Range (ATR)
- AZZ 2.32
- SUPN 1.69
- MACD
- AZZ 0.48
- SUPN 0.03
- Stochastic Oscillator
- AZZ 62.30
- SUPN 36.03
About AZZ AZZ Inc.
AZZ Inc is a provider of galvanizing and a variety of metal coating solutions and coil coating solutions to a broad range of end markets in North America. In its Metal Coatings segment, the company offers metal finishing services to protect against corrosion, such as hot dip galvanizing, spin galvanizing, powder coating, anodizing, and plating. The Precoat Metals Segment offers aesthetic and corrosion-resistant coatings for steel and aluminum coils.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.